• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3: New insider Havencrest Healthcare Partners, L.P. claimed ownership of 15,662,794 shares

    11/22/21 4:28:08 PM ET
    $DFPH
    Business Services
    Finance
    Get the next $DFPH alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Havencrest Healthcare Partners, L.P.

    (Last) (First) (Middle)
    2100 MCKINNEY AVE, SUITE 1760

    (Street)
    DALLAS TX 75201

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    11/12/2021
    3. Issuer Name and Ticker or Trading Symbol
    Oncology Institute, Inc. [ TOI ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Common stock(1) 15,662,794 I See footnote(2)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Earnout Shares (Common Stock) (3) (3) Common Stock 1,330,071 (3) I See footnote(2)
    Earnout Shares (Common Stock) (4) (4) Common Stock 1,995,106 (4) I See footnote(2)
    1. Name and Address of Reporting Person*
    Havencrest Healthcare Partners, L.P.

    (Last) (First) (Middle)
    2100 MCKINNEY AVE, SUITE 1760

    (Street)
    DALLAS TX 75201

    (City) (State) (Zip)
    1. Name and Address of Reporting Person*
    Havencrest Healthcare Partners GP, LLC

    (Last) (First) (Middle)
    2100 MCKINNEY AVE, SUITE 1760

    (Street)
    DALLAS TX 75201

    (City) (State) (Zip)
    1. Name and Address of Reporting Person*
    TOI HC I, LLC

    (Last) (First) (Middle)
    2100 MCKINNEY AVE, SUITE 1760

    (Street)
    DALLAS TX 75201

    (City) (State) (Zip)
    Explanation of Responses:
    1. Received on November 12, 2021, as consideration pursuant to that certain Agreement and Plan of Merger ("Merger Agreement"), dated as June 28, 2021, by and among DFP Healthcare Acqusitions Corp. (the "Issuer"), Orion Merger Sub I, Inc., Orion Merger Sub II, LLC, and TOI Parent, Inc. (such transactions therein, collectively, the "Business Combination").
    2. TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.
    3. Received as part of the consideration in the Business Combination. Represents the right to receive shares of common stock (i) in the event the Issuer's stock price equals or exceeds (x) $12.50 per share for 20 days within any 30 consecutive trading days during the two-year period following the closing of the Business Combination, or (y) $15.00 per share for any 20 trading days within any 30-day trading period during the three-year period following the closing of the Business Combination, or (ii) in the event of a qualifying change of control.
    4. Received as part of the consideration in the Business Combination. Represents the right to receive shares of common stock (i) in the event the Issuer's stock price equals or exceeds $15.00 per share for any 20 trading days within any 30-day trading period during the three-year period following the closing of the Business Combination, or (ii) in the event of a qualifying change of control.
    Remarks:
    /s/ Havencrest Healthcare Partners, L.P., by Christopher W. Kersey as Manager and President of Havencrest Healthcare Partners GP, LLC 11/22/2021
    /s/ Havencrest Healthcare Partners GP, LLC, by Christopher W. Kersey as Manager and President 11/22/2021
    /s/ TOI HC I, LLC, by Christopher W. Kersey as Manager 11/22/2021
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $DFPH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DFPH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DFPH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3: New insider M33 Growth I L.P. claimed ownership of 15,256,383 shares

    3 - Oncology Institute, Inc. (0001799191) (Issuer)

    11/22/21 4:38:03 PM ET
    $DFPH
    Business Services
    Finance

    SEC Form 3: New insider Havencrest Healthcare Partners, L.P. claimed ownership of 15,662,794 shares

    3 - Oncology Institute, Inc. (0001799191) (Issuer)

    11/22/21 4:28:08 PM ET
    $DFPH
    Business Services
    Finance

    SEC Form 4: Sarin Ravi Yang was granted 4,109,771 shares (Amendment)

    4/A - Oncology Institute, Inc. (0001799191) (Issuer)

    11/22/21 4:15:17 PM ET
    $DFPH
    Business Services
    Finance

    $DFPH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Oncology Institute Physician, Dr. John Khoury, Receives 40 Under 40 in Cancer Award

    This is the second year in a row a TOI physician was recognized The Oncology Institute (TOI) is proud to announce that Dr. John Khoury was recently awarded the "40 Under 40 in Cancer" award by the Association for Value-Based Cancer Care. This is the second year in a row a TOI physician was recognized for this honor. Dr. Omkar Marathe was selected for the distinction in 2020. "It's an honor to be part of such a distinguished list of young oncology professionals and leaders who work very hard to improve the lives of those affected by cancer," said Dr. Khoury. Dr. John Khoury is a triple board-certified physician who joined The Oncology Institute in 2020. He completed his residency and fell

    11/9/21 9:15:00 AM ET
    $DFPH
    Business Services
    Finance

    DFP Healthcare Acquisitions Corp. Announces Special Meeting Date to Approve Proposed Business Combination with The Oncology Institute

    Special Meeting of Stockholders Scheduled for November 12, 2021 DFP Healthcare Acquisitions Corp. ("DFP") (NASDAQ:DFPH) announced today that it has scheduled the special meeting of its stockholders (the "Special Meeting") for November 12, 2021 at 10:00 a.m., Eastern Time, to approve the proposed business combination (the "Business Combination") with The Oncology Institute ("TOI" or the "Company"), the U.S. market leader in providing value-based oncology care. DFP also announced that it has filed its definitive proxy statement/prospectus for the Special Meeting and has commenced mailing the definitive proxy statement/prospectus to its stockholders of record as of September 23, 2021, the re

    10/22/21 4:05:00 PM ET
    $DFPH
    Business Services
    Finance

    The Oncology Institute of Hope and Innovation (TOI) Expands to San Diego County

    Two state-of-the-art clinics opening in Vista and Chula Vista with a third in Hillcrest slated for later this year The Oncology Institute of Hope and Innovation (TOI) began seeing patients this week at two new locations in Vista and Chula Vista, marking the community-based oncology provider's entry into San Diego County. A third location in Hillcrest is slated to open in the fall. Founded in 2007, TOI is a multi-state cancer care practice dedicated to healing and empowering patients through compassion, innovation, and state-of-the-art medical care. TOI is the largest value-based oncology practice in the U.S., taking accountability for both the quality outcomes as well as the medical costs

    8/4/21 12:05:00 PM ET
    $DFPH
    Business Services
    Finance

    $DFPH
    SEC Filings

    View All

    DFP Healthcare Acquisitions Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (Amendment)

    8-K/A - Oncology Institute, Inc. (0001799191) (Filer)

    11/22/21 5:18:03 PM ET
    $DFPH
    Business Services
    Finance

    DFP Healthcare Acquisitions Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Registrant’s Certifying Accountant, Changes in Control of Registrant, Leadership Update, Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics, Other Events, Financial Statements and Exhibits

    8-K - Oncology Institute, Inc. (0001799191) (Filer)

    11/18/21 5:29:51 PM ET
    $DFPH
    Business Services
    Finance

    SEC Form 25-NSE filed by DFP Healthcare Acquisitions Corp.

    25-NSE - DFP HEALTHCARE ACQUISITIONS CORP. (0001799191) (Subject)

    11/12/21 4:20:20 PM ET
    $DFPH
    Business Services
    Finance

    $DFPH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by DFP Healthcare Acquisitions Corp.

    SC 13D - Oncology Institute, Inc. (0001799191) (Subject)

    11/22/21 4:41:54 PM ET
    $DFPH
    Business Services
    Finance

    SEC Form SC 13D filed by DFP Healthcare Acquisitions Corp.

    SC 13D - Oncology Institute, Inc. (0001799191) (Subject)

    11/22/21 4:25:01 PM ET
    $DFPH
    Business Services
    Finance

    SEC Form SC 13D filed by DFP Healthcare Acquisitions Corp.

    SC 13D - Oncology Institute, Inc. (0001799191) (Subject)

    11/22/21 4:19:36 PM ET
    $DFPH
    Business Services
    Finance